PARIS, Dec 24 (Reuters) - French medical regulator HAS said on Thursday it has approved the vaccine developed by Pfizer and BioNTech for France’s vaccination rollout, after the European Medicines Agency gave its go-ahead on Monday.
“The vaccine can be used for people aged 16 and over, including elderly”, the regulator says. (Reporting by Matthieu Protard; Editing by Edmund Blair)
我们的标准: 汤森路透“信任原则”